Key result
Novel CABE index shows fair discrimination for moderate-to-severe CAD burden with ~0.73 AUC.
Why the study?
Simple and accessible tools using routinely available clinical and metabolic parameters are needed to estimate coronary angiographic disease burden and facilitate risk stratification in resource-limited settings.
Does the Coronary Angiographic Burden Estimation (CABE) Index based on age, fasting blood glucose, and atherogenic index of plasma accurately estimate moderate-to-severe coronary angiographic disease burden in patients undergoing coronary angiography?
Cohort (n=580)
No
Does the Coronary Angiographic Burden Estimation (CABE) Index based on age, fasting blood glucose, and atherogenic index of plasma accurately estimate moderate-to-severe coronary angiographic disease burden in patients undergoing coronary angiography?
Answers are grounded in this paper and cite their sources.
The CABE index provides a simple, accessible tool using routine clinical and metabolic parameters (age, fasting blood glucose, and atherogenic index of plasma) to estimate moderate-to-severe coronary angiographic burden with fair discrimination, potentially aiding risk stratification in resource-limited settings.
Background: Coronary artery disease remains a major contributor to morbidity and mortality worldwide. Simple and accessible tools for estimating coronary angiographic disease burden may facilitate risk stratification, particularly in settings with limited resources. Objective: To develop and temporally internally validate a practical index for estimating coronary angiographic disease burden using routinely available clinical and metabolic parameters. Methods: We retrospectively analyzed medical records of 414 patients for model derivation and 166 patients for temporal internal validation, who underwent coronary angiography at Dr. Ramelan Naval Central Hospital between 2024 and 2025. Angiographic burden was classified as mild (Gensini score <11) or moderate-to-severe (≥11). Candidate predictors were evaluated using logistic regression, and model performance was assessed using receiver operating characteristic (ROC) analysis. Result: Older age, higher fasting blood glucose (FBG), and atherogenic index of plasma (AIP) were independently associated with greater CAD burden (all p < 0.05), and were incorporated into the Coronary Angiographic Burden Estimation (CABE) Index. The model demonstrated fair discrimination in the derivation cohort (AUC 0.726;60.5% sensitivity and 73.2% specificity at the predefined cutoff) and showed consistent performance in the temporal validation cohort (AUC 0.729). Conclusion: The CABE index is a simple, association-based tool that estimates the likelihood of higher coronary angiographic burden using routinely available clinical and metabolic parameters. . The index demonstrated fair discrimination and consistent temporal validation performance. Further external multicenter validation is required before its broader application in clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Zenjaya et al. (2026) conducted a cohort in Coronary artery disease (n=580). Coronary Angiographic Burden Estimation (CABE) Index (age, fasting blood glucose, and atherogenic index of plasma) was evaluated on Moderate-to-severe coronary angiographic disease burden (Gensini score >=11 vs <11) (AUC 0.726, p=<0.05). The CABE index (age, FBG, and AIP) showed fair discrimination for moderate-to-severe CAD burden in derivation and validation cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: